The Role of Chimerism Following Hematopoietic Stem Cell Transplantation
White Paper
Related Information
Download
Download & Print ❯
Resources
View search results for more transplantation related articles.
Scientific Research ❯
Related Products
LABScreen COVID Plus ❯
LabScreen Single Antigen ❯
Related Links
Coronavirus disease (COVID-19) training: Online training ❯
COVID-19 vs. SARS: How Do They Differ? ❯
This white paper explores the use of hematopoietic stem cell transplantation (HSCT) as a curative treatment for patients with malignant or nonmalignant hematological diseases, as well as the benefits of monitoring for chimerism after HSCT.
Learn how laboratories and clinicians can use the best monitoring techniques available to minimize the risk of missing out on valuable information needed to identify minimal residual disease (MRD) and prevent relapse. Select the link below to read the white paper in full.
